The more commonly used class III ferroptosis inducers are FSP1 inhibitor (which inhibits FSP1 activity and reduces coenzyme Q10 production) (134), statins (which inhibit the mevalonate pathway) (135,136), and class IV ferroptosis inducers, such as heme (which increases the amount of intracellular iron in the unstable state) (137) and artemisinin (which induces ferritin autophagy, causing the release of iron in the unstable state) (138)
Citation: Clemmons DR, Miller S, Mamputu J-C (2017) Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial
GHK facilitates controlled copper uptake into cells, and unlike copper salts, GHK-Cu does NOT cause oxidative damage while actually exhibiting antioxidant properties by preventing free copper-induced lipid peroxidation
At each step of the psoriasis molecular pathway, different inflammatory cytokines such as IL-6, IL-17, IL-22, and IL-23 are triggered, on the other side, growth factors such as EGF, VEGF, KGF, and IGF-1, which underscores the central role which predominantly drives epidermal hyperplasia [12, 56, 57]